​Sickle Cell Disease Regional Care Excellence (SoRCE) Program
Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD. Treatment starting in
| Agency | Health Resources and Services Administration |
|---|---|
| Status | Posted |
| Opportunity number | HRSA-26-052 |
| Posted date | 06/05/2026 |
| Application deadline | Jul 08, 2026 12:00:00 AM EDT |
| Award ceiling | 950,000 |
| Award floor | 0 |
| Estimated total funding | 6,650,000 |
| Expected number of awards | 7 |
| Who can apply | Hospitals or clinicsHealth centers. |
| Assistance Listing (CFDA) | 93.365 |
| Description | Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD. Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death. Despite universal identification at birth, fewer than half of children with SCD receive needed treatment. As these children become adolescents and transition to adulthood many are not appropriately identified as candidates for disease-modifying therapies, in part because their doctors are still learning how to use the latest treatments. The program is made up |
| Agency contact | scdprograms@hrsa.gov |
| Official listing | https://www.grants.gov/search-results-detail/360997 |